Research Articles

Peer-reviewed studies distilled into actionable summaries. Updated daily.

Total: 57,155 articles • Showing 2 of 57,155
pubmed

Durvalumab plus anlotinib versus durvalumab alone as maintenance treatment in extensive-stage small-cell lung cancer (DURABLE): a multicenter, randomized, phase II trial and biomarker analysis.

Zhang B; Zhong R; Shi C; Chu T; Zhang W; Wang H; Gan X; Zhang Z; Zhu C; Li X; Su W; Li J; Zhang Y; Han B; Zhong H

The research studied a new treatment for a type of lung cancer to see if it works better than the standard treatment. They found that using two drugs together, durvalumab and anlotinib, helped people live longer without the cancer getting worse compared to just using durvalumab. However, some people had stronger side effects with the two-drug treatment.

View Details
pubmed

Reference-guided genome assembly of long non-coding rna transcripts reveals target genes associated with Crohn's disease.

Kennedy Ng MM; Silverstein S; Nishiyama NC; Beasley C; Lian G; Huan B; Lau G; Weaver D; Awad A; Schaner MR; Sheikh SZ; Furey TS

Researchers studied special molecules called long non-coding RNAs (lncRNAs) to understand Crohn's disease better. They found new lncRNAs that might affect how the disease works by looking at RNA from people with this illness. They also found out how some lncRNAs might help control important genes linked to Crohn's disease.

View Details
🔒

Unlock 57,153+ More Articles

Upgrade to the Weekly Digest and get unlimited access to all research articles, plain-language takeaways, and our AI research assistant.

or

Get the science breakthroughs you need—
every Tuesday morning.

We scan 70+ journals so you don't have to.
One email. Zero jargon. Unsubscribe anytime.

Want to see what you'll get?

View Sample: Alcohol, Crops, and Activism

🔒 No spam. 1-click opt-out. Privacy-first.